Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Essential Drugs Monitor No. 032 (2003)
(2003; 48 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoEDITORIAL - 25 years of essential medicines progress
Ver el documentoANNIVERSARY ISSUE - Improving drug regulation
Ver el documentoDrug pricing survey in KwaZulu-Natal
Ver el documentoReducing costs through regional pooled procurement
Ver el documentoDispensing prescribers - a threat to appropriate medicines use?
Ver el documentoDrug and therapeutics committees: vehicles for improving rational drug use
Ver el documentoAnnouncing ICIUM 2004
Ver el documentoAccess to essential medicines: a global necessity
Ver el documentoMemories of the First Expert Committee Meeting and celebrating 25 years later
Ver el documento25 years of essential medicines: events around the world
Ver el documentoPersonal reflections on 25 years of the WHO Model List of Essential Medicines
Ver el documentoDrug utilization in Latin America - the example of DURG-LA
Ver el documentoGlobal TB Drug Facility: improving access to TB drugs
Ver el documentoDemystifying antiretroviral therapy in resource-poor settings
Ver el documentoCBIA: improving the quality of self-medication through mothers’ active learning
Ver el documentoIndian hospital drug use study shows need to improve prescribing
Ver el documentoWHO’s new Model Formulary - promoting consumer rights and patient safety

Essential Drugs Monitor No. 032 (2003)


Essential Drugs Monitor

The Essential Drugs Monitor is produced and distributed by the WHO Department of Essential Drugs and Medicines Policy (EDM). It is published in Chinese, English, French, Spanish and Russian, and has a global readership of some 300,000 to whom it is free of charge. The Monitor carries news of developments in national drug policies, therapeutic guidelines, current pharmaceutical issues, educational strategies and operational research.

WHO’s Department of Essential Drugs and Medicines Policy seeks to ensure that all people - wherever they may be - are able to obtain the drugs they need at a price that they and their country can afford; that these drugs are safe, effective and of good quality; and that they are prescribed and used rationally.

All correspondence should be addressed to:

The Editor
Essential Drugs Monitor
World Health Organization
CH-1211 Geneva 27, Switzerland
Fax: +41 22-791-4167


Ir a la siguiente sección
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019